Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Bimekizumab for the treatment of moderate to severe psoriasis: a real-world experience over 52 weeks from two Italian dermatology clinics.

The Journal of dermatological treatment·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).

The Journal of dermatological treatment·2024
Same author

Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same journal

Identification of circRNA-mediated competing endogenous RNA network in the development of bladder urothelial carcinoma.

Journal of biological regulators and homeostatic agents·2021
Same journal

Dimethyl fumarate attenuates lipopolysaccharide-induced acute lung injury by inhibiting inflammation and oxidative stress.

Journal of biological regulators and homeostatic agents·2021
Same journal

Expression of NLR and IL-1β and their predictive efficacy value in acute myocardial infarction patients treated with aspirin combined with clopidogrel.

Journal of biological regulators and homeostatic agents·2021
Same journal

CircRNA (circ_0008057) promotes uremic serum-mediated proliferation and migration of vascular smooth muscle cells via miR-370/PLk1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Overexpression of miR-150-5p alleviates lipopolysaccharide-induced A549 cell injury in type II alveolar epithelial cells by inhibiting the FSTL1 signaling pathway.

Journal of biological regulators and homeostatic agents·2021
Same journal

Efficacy of early oral and perioral physiotherapy on feeding autonomy in preterm infants: results of randomized controlled trials.

Journal of biological regulators and homeostatic agents·2021
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

953

Clusterin serum level: how does it affect psoriatic patients?

R Buquicchio1, C Foti1, F Loconsole1

  • 1Dermatological Clinic, Department of Biomedical Science and Human Oncology, University of Bari Medical School, Policlinico, Italy

Journal of Biological Regulators and Homeostatic Agents
|September 30, 2017
PubMed
Summary
This summary is machine-generated.

Serum clusterin (Clu) levels are significantly elevated in psoriasis patients, suggesting its potential role in disease pathogenesis and as a marker for associated metabolic and cardiovascular comorbidities.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

917
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

14.8K

Related Experiment Videos

Last Updated: Feb 22, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

953
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

917
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

14.8K

Area of Science:

  • Dermatology
  • Biochemistry
  • Immunology

Background:

  • Psoriasis is a chronic inflammatory skin condition with systemic implications.
  • Psoriasis is linked to comorbidities like metabolic syndrome and cardiovascular disorders.
  • Clusterin (Clu), or apolipoprotein J (ApoJ), is involved in numerous physiological and pathological processes.

Purpose of the Study:

  • To investigate serum clusterin (Clu) levels in patients with moderate-to-severe psoriasis.
  • To explore the potential association between Clu levels and psoriasis comorbidities.

Main Methods:

  • Serum Clu levels were measured in 15 patients with moderate-to-severe psoriasis (Psoriasis Area and Severity Index ≥ 10).
  • Patient Clu levels were compared to those of healthy subjects.

Main Results:

  • Serum Clu levels were significantly higher in psoriasis patients compared to healthy individuals (p < 0.001).
  • Elevated Clu levels may correlate with psoriasis-related metabolic and cardiovascular comorbidities.

Conclusions:

  • Increased serum Clu is observed in psoriasis patients.
  • Clu may play a role in psoriasis pathogenesis and its associated comorbidities.
  • Further research with larger cohorts is needed to validate Clu as a biomarker for psoriasis prognosis.